Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review

[1]  S. Bridenbaugh,et al.  Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial , 2022, Journal of the American Society of Nephrology : JASN.

[2]  M. Christ-Crain,et al.  Effect of Hyponatremia Normalization on Osteoblast Function in Patients with SIAD. , 2021, European Journal of Endocrinology.

[3]  M. Christ-Crain,et al.  Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers? , 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  A. Ortiz,et al.  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication? , 2020, American Journal of Nephrology.

[5]  I. Lee,et al.  Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus , 2020, Medicine.

[6]  M. Christ-Crain,et al.  A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis. , 2020, Journal of the American Society of Nephrology : JASN.

[7]  W. Inder,et al.  Urea treatment in fluid restriction‐refractory hyponatraemia , 2019, Clinical endocrinology.

[8]  Marc P. Bonaca,et al.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.

[9]  M. Christ-Crain,et al.  Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis , 2017, International journal of endocrinology.

[10]  C. Schoergenhofer,et al.  Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with Empagliflozin , 2017, Drug Safety - Case Reports.

[11]  J. Glanville,et al.  A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta‐analysis of the vaptans , 2017, Clinical endocrinology.

[12]  M. Christ-Crain,et al.  Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis , 2016, Journal of internal medicine.

[13]  D. Annane,et al.  Clinical practice guideline on diagnosis and treatment of hyponatraemia , 2014, Intensive Care Medicine.

[14]  Arthur Greenberg,et al.  Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. , 2013, The American journal of medicine.

[15]  D. Lowance,et al.  The syndrome of inappropriate antidiuresis. , 2007, The New England journal of medicine.